24. Saleh J, Mercier B, Xi W. Bioengineering methods for organoid systems. Biol Cell 2021;113:475-91.
25. Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and disease using organoid technologies. Science 2014;345:1247125.
28. Hernández D, Rooney LA, Daniszewski M, Gulluyan L, Liang HH, Cook AL, et al. Culture variabilities of human iPSC-derived cerebral organoids are a major issue for the modelling of phenotypes observed in Alzheimer's disease. Stem Cell Rev Rep 2021 Mar 16 [Epub].
https://doi.org/10.1007/s12015-021-10147-5.
32. Nam SA, Seo E, Kim JW, Kim HW, Kim HL, Kim K, et al. Graft immaturity and safety concerns in transplanted human kidney organoids. Exp Mol Med 2019;51:1-13.
38. Saxena S, Joshi R. Microfluidic devices: applications and role of surface wettability in its fabrication. In: Pham P, Goel P, Kumar S, Yadav K, editors. 21st century surface science-a handbook. London: IntechOpen; 2020. p. 147.
39. Berlanda SF, Breitfeld M, Dietsche CL, Dittrich PS. Recent advances in microfluidic technology for bioanalysis and diagnostics. Anal Chem 2021;93:311-31.
40. Rabiee M, Ghasemnia NN, Rabiee N, Bagherzadeh M. Microfluidic devices for drug delivery systems. In: Hamblin M, Karimi M, editors. Biomedical applications of microfluidic devices. Cambridge, Massachusetts: Elsevier; 2021. p. 153-86.
41. Zhong Q, Ding H, Gao B, He Z, Gu Z. Advances of microfluidics in biomedical engineering. Adv Mater Technol 2019;4:1800663.
43. Wang Z, He X, Qiao H, Chen P. Global trends of organoid and organ-on-a-chip in the past decade: a bibliometric and comparative study. Tissue Eng Part A 2020;26:656-71.
47. Shirure VS, Hughes CCW, George SC. Engineering vascularized organoid-on-a-chip models. Annu Rev Biomed Eng 2021;23:141-67.
48. Wang Y, Wang L, Zhu Y, Qin J. Human brain organoid-on-a-chip to model prenatal nicotine exposure. Lab Chip 2018;18:851-60.
60. de Souza N. Organoid variability examined. Nat Methods 2017;14:655.
69. Wang Y, Wang H, Deng P, Chen W, Guo Y, Tao T, et al. In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system. Lab Chip 2018;18:3606-16.
74. Soriano E, Del Río JA. The cells of cajal-retzius: still a mystery one century after. Neuron 2005;46:389-94.
76. Taguchi A, Kaku Y, Ohmori T, Sharmin S, Ogawa M, Sasaki H, et al. Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell Stem Cell 2014;14:53-67.
79. Rishi G, Subramaniam VN. The liver in regulation of iron homeostasis. Am J Physiol Gastrointest Liver Physiol 2017;313:G157-65.
80. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol 2019;70:151-71.
84. Skardal A, Aleman J, Forsythe S, Rajan S, Murphy S, Devarasetty M, et al. Drug compound screening in single and integrated multi-organoid body-on-a-chip systems. Biofabrication 2020;12:025017.